Welcome to the homepage of the Institute of Biomedical Technology

From the beginning of the year 2011, Regea Institute for Regenerative Medicine and Institute of Medical Technology are united and form the Institute of Biomedical Technology (IBT). The new institute cooperates closely with the institutes at Tampere University of Technology (TUT) engaging in the field. The aim is to create an interdisciplinary, internationally high standard research and education institute (BioMediTech), operating on the interface of biomedicine and technology. It also aims to contribute to creating new innovations and businesses. For this purpose, the project has received funding both from the European Regional Development Fund and from the Council of Tampere Region.

BioMediTech News BioMediTech receives 1,2 million for equipment investments The Regional Board has granted 1 245 000 euros to the University of Tampere and Tampere University of Technology for a development project of BioMediTech research infrastructure. The funding originates from the European Regional Development Fund (ERDF) and from State co-financing. The funding enables BioMediTech to procure new equipment for developing new technologies. With the new equipment BioMediTech is expected to increase the amount of innovations and international business in Finland and the Pirkanmaa area. Full cost evaluation of the project is 4,6 million euros. ERDF and State funding are 2,3 million euros and other public funding 2,3 million euros. Development of BioMediTech is a spearhead project of the Pirkanmaa Regional Programme 2011–2014. Open positions in BioMediTech: In English In Finnish

IBT International Seminar Programme on Mondays, FM5 auditorium seminar program